Showing results (471-480 of 868) with videos related to

Sort By:
Pageof 87
Journal of Health Care for the Poor and Underserved|February 20, 2010
The impact of mass incarceration on outpatients in the Bronx: a card studyMinesh P Shah, Sadiqa Edmonds-Myles, Matthew Anderson, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|September 12, 2013
Cognitive reserve protects against apathy in individuals with human immunodeficiency virusMiriam E Shapiro, Jeannette R Mahoney, Deena Peyser, et al.
JIMD Reports|August 26, 2015
Mucopolysaccharidosis (MPS) Physical Symptom Score: Development, Reliability, and ValidityA Ahmed, K Rudser, A Kunin-Batson, et al.
The Journal of Surgical Research|February 15, 2021
A Pilot Study of Surgical Trainee Participation in Humanitarian SurgeriesJulia Riccardi, Vennila Padmanaban, Frank T Padberg, et al.
The Lancet Regional Health. Southeast Asia|June 29, 2023
A systematic review and meta-analysis of active case finding for tuberculosis in IndiaTushar Garg, Lelia H Chaisson, Fahd Naufal, et al.
The Prostate|November 20, 1997
Morphometric analysis of pediatric and nonhyperplastic prostate glands: evidence that BPH is not a unique stromal processE Shapiro, V Hartanto, E J Perlman, et al.
Biochemistry|June 1, 2000
Backbone dynamics of escherichia coli adenylate kinase at the extreme stages of the catalytic cycle studied by (15)N NMR relaxationY E Shapiro, M A Sinev, E V Sineva, et al.
Obstetrics and Gynecology|November 27, 1999
Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study GroupD E Shapiro, R S Sperling, L Mandelbrot, et al.
Cancer Research|July 23, 1999
Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinomaZ T Zhang, J Pak, E Shapiro, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 7, 2009
Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatmentBarbara E Shapiro, Gregory M Pastores, John Gianutsos, et al.
Pageof 87